Aichi, Japan

Kihachiro Izumi


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kihachiro Izumi: Innovator in Pharmaceutical Chemistry

Introduction

Kihachiro Izumi is a notable inventor based in Aichi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. His work has been recognized for its potential impact on medical treatments.

Latest Patents

Izumi holds a patent for 1,5-Benzothiazepine compounds. These compounds are represented by the formula (I), wherein R₁ can be a hydrogen atom, a halogen atom, an alkyl group, or an alkoxy group, while R₂ can be a hydrogen atom, an alkyl group, or a hydroxyalkyl group. The patent also covers the pharmaceutically acceptable acid addition salts and quaternary ammonium salts of these compounds, which exhibit anticholinergic activity. They are useful as anti-ulcer, gastric secretion inhibiting, and antispasmodic agents in mammals.

Career Highlights

Kihachiro Izumi is associated with Maruko Seiyaku Co., Ltd., where he has been instrumental in advancing pharmaceutical research. His innovative work has contributed to the development of new therapeutic agents that address various medical conditions.

Collaborations

Izumi has collaborated with notable colleagues such as Sachio Ohno and Kiyoshi Mizukoshi. These partnerships have fostered a collaborative environment that enhances research and development efforts in the pharmaceutical industry.

Conclusion

Kihachiro Izumi's contributions to pharmaceutical chemistry, particularly through his patent on 1,5-Benzothiazepine compounds, highlight his role as an innovator in the field. His work continues to influence the development of effective medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…